drugset / Trial / NCT01407276
A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a 2-part study in participants with renal impairment and matched healthy participants to investigate the effect of impaired renal function on the plasma and urine levels of omarigliptin (MK-3102) after taking a single 3 mg dose by mouth.
Timeline
- Start
- 2011-08-08
- Primary completion
- 2012-03-23
- Completion
- 2012-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omarigliptin | Small molecule | 3 mg | Oral |